Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
出版年份 2022 全文链接
标题
Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 11, Issue 10, Pages 2865
出版商
MDPI AG
发表日期
2022-05-20
DOI
10.3390/jcm11102865
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Proton pump inhibitors and risk of gastric cancer: population-based cohort study
- (2021) Devin Abrahami et al. GUT
- Hepatocellular carcinoma statistics in South Korea
- (2021) Young Eun Chon et al. Clinical and Molecular Hepatology
- Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis
- (2020) Nasser Alkhushaym et al. Expert Opinion On Drug Safety
- Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis
- (2020) Hyun Jin Song et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Use of proton pump inhibitors and the risk of hepatocellular carcinoma
- (2019) Tien-En Chang et al. Journal of the Chinese Medical Association
- International trends in hepatocellular carcinoma incidence, 1978–2012
- (2019) Jessica L. Petrick et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
- (2019) Nele Brusselaers et al. JOURNAL OF GASTROENTEROLOGY
- Association between proton pump inhibitors and the risk of hepatocellular carcinoma
- (2018) Y.-H. J. Shao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies
- (2018) K. T. Tran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
- (2018) In Cheol Hwang et al. PLoS One
- Long-term proton pump inhibitors and risk of gastric cancer development after treatment forHelicobacter pylori: a population-based study
- (2017) Ka Shing Cheung et al. GUT
- Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea
- (2017) Sang Cheol Seong et al. BMJ Open
- Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
- (2017) In Cheol Hwang et al. PLoS One
- Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea
- (2016) Sang Cheol Seong et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Adverse Effects Associated With Proton Pump Inhibitors
- (2016) Adam Jacob Schoenfeld et al. JAMA Internal Medicine
- Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival
- (2015) Reidar Fossmark et al. APMIS
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
- (2010) Ju Dong Yang et al. Clinical Gastroenterology and Hepatology
- The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
- (2008) J. Polesel et al. ANNALS OF ONCOLOGY
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis
- (2008) Asmaa Ibrahim Gomaa et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started